A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX
Clinical trial NCT01855789 · COMPLETED
Trial details
- NCT number
- NCT01855789
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-07
- Primary completion
- 2016-10-14
- Enrollment
- 718
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.